Literature DB >> 7494570

Schizophrenia.

J M Kane1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 7494570     DOI: 10.1056/NEJM199601043340109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  45 in total

Review 1.  Past and present progress in the pharmacologic treatment of schizophrenia.

Authors:  John M Kane; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

Review 2.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.

Authors:  Irene Seunghyun Hong; Jeffrey R Bishop
Journal:  Ann Pharmacother       Date:  2010-06-29       Impact factor: 3.154

Review 4.  Unanswered questions in schizophrenia clinical trials.

Authors:  John M Kane; Stefan Leucht
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

5.  Re: CCNP position paper on the use of placebos in psychiatry.

Authors:  W C Friend; C Weijer
Journal:  J Psychiatry Neurosci       Date:  1996-11       Impact factor: 6.186

6.  Predicting pharmacokinetic stability by multiple oral administration of atypical antipsychotics.

Authors:  Akihide Wakamatsu; Kazuo Aoki; Yojiro Sakiyama; Takashi Ohnishi; Makoto Sugita
Journal:  Innov Clin Neurosci       Date:  2013-03

Review 7.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 8.  Treatment refractory schizophrenia: how should we proceed?

Authors:  Z A Sharif
Journal:  Psychiatr Q       Date:  1998

9.  Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia.

Authors:  Xinhua S Ren; Lawrence Herz; Shirley Qian; Eric Smith; Lewis E Kazis
Journal:  Neuropsychiatr Dis Treat       Date:  2009-10-12       Impact factor: 2.570

10.  Study of cenesthesias and body image aberration in schizophrenia.

Authors:  Gaurav Rajender; Krishna Kanwal; Dinesh M Rathore; Deepa Chaudhary
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.